Press

Featured In

Irish Times
October 14, 2024

‘A Day of Hope’: Irish Hospital Patients Get Access to ‘Early Phase’ Cancer Drugs

Featured In

BusinessWire
October 8, 2024

First Patient Dosed with NILK-2401 in Phase I Clinical Trial

Featured In

Applied Clinical Trials
September 18, 2024

DPharm 2024: Problem Solving in the Clinical Trial Realm

Featured In

Opna Bio
August 26, 2024

Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor

Featured In

BusinessWire
August 19, 2024

MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor

Featured In

Clinical Leader
July 29, 2024

Why Moving More Cancer Trials Into the Community Benefits Patients and Sponsors